99 related articles for article (PubMed ID: 10069453)
1. Defining the substrate specificity of cdk4 kinase-cyclin D1 complex.
Grafstrom RH; Pan W; Hoess RH
Carcinogenesis; 1999 Feb; 20(2):193-8. PubMed ID: 10069453
[TBL] [Abstract][Full Text] [Related]
2. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
Pan W; Cox S; Hoess RH; Grafström RH
Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
[TBL] [Abstract][Full Text] [Related]
3. Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex.
Pan W; Sun T; Hoess R; Grafstrom R
Carcinogenesis; 1998 May; 19(5):765-9. PubMed ID: 9635861
[TBL] [Abstract][Full Text] [Related]
4. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4.
Leng X; Noble M; Adams PD; Qin J; Harper JW
Mol Cell Biol; 2002 Apr; 22(7):2242-54. PubMed ID: 11884610
[TBL] [Abstract][Full Text] [Related]
5. Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4.
Wallace M; Ball KL
Mol Cell Biol; 2004 Jun; 24(12):5606-19. PubMed ID: 15169919
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
Kim DM; Yang K; Yang BS
Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
[TBL] [Abstract][Full Text] [Related]
7. The cyclin D1-dependent kinase associates with the pre-replication complex and modulates RB.MCM7 binding.
Gladden AB; Diehl JA
J Biol Chem; 2003 Mar; 278(11):9754-60. PubMed ID: 12519773
[TBL] [Abstract][Full Text] [Related]
8. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
9. Activation of cyclin D1-Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy.
Féliers D; Frank MA; Riley DJ
Diabetes; 2002 Nov; 51(11):3290-9. PubMed ID: 12401721
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex.
Wang J; Walsh K
Cell Growth Differ; 1996 Nov; 7(11):1471-8. PubMed ID: 8930396
[TBL] [Abstract][Full Text] [Related]
11. The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression.
Sterner JM; Tao Y; Kennett SB; Kim HG; Horowitz JM
Cell Growth Differ; 1996 Jan; 7(1):53-64. PubMed ID: 8788033
[TBL] [Abstract][Full Text] [Related]
12. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
[TBL] [Abstract][Full Text] [Related]
13. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
Takaki T; Fukasawa K; Suzuki-Takahashi I; Semba K; Kitagawa M; Taya Y; Hirai H
J Biochem; 2005 Mar; 137(3):381-6. PubMed ID: 15809340
[TBL] [Abstract][Full Text] [Related]
14. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells.
Guo J; Sheng G; Warner BW
J Biol Chem; 2005 Oct; 280(43):35992-8. PubMed ID: 16126730
[TBL] [Abstract][Full Text] [Related]
16. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.
Suzuki-Takahashi I; Kitagawa M; Saijo M; Higashi H; Ogino H; Matsumoto H; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 May; 10(9):1691-8. PubMed ID: 7753545
[TBL] [Abstract][Full Text] [Related]
17. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity.
Siegert JL; Rushton JJ; Sellers WR; Kaelin WG; Robbins PD
Oncogene; 2000 Nov; 19(50):5703-11. PubMed ID: 11126356
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the myristoylated protein kinase C substrate MARCKS by the cyclin E-cyclin-dependent kinase 2 complex in vitro.
Manenti S; Yamauchi E; Sorokine O; Knibiehler M; Van Dorsselaer A; Taniguchi H; Ducommun B; Darbon JM
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):775-82. PubMed ID: 10359664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
